Remifentanil Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Remifentanil Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Jun 28, 2022. Reported reason: Delay in shipping of the drug
Shortage details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-723-03
- Dosage Form
- Injection
- Presentation
- Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03)
- Initial Posting
- Jun 28, 2022
Reason
Delay in shipping of the drug